Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements
This document provides guidance on brand name assessment, inner and outer product labels, and risk management planning.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records